<DOC>
	<DOCNO>NCT00809042</DOCNO>
	<brief_summary>The purpose study determination efficacy combination hydroxyurea L-carnitine magnesium improve hematologic parameter cardiac status patient β-thalassemia intermedia comparison hydroxyurea alone .</brief_summary>
	<brief_title>Combination Therapy Hydroxyurea With L-Carnitine Magnesium Chloride Thalassemia Intermedia</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Beta thalassemia intermedia patient mean hemoglobin level &gt; = 7gr/dl , need blood transfusion 6 month interval need blood transfusion Hypothyroidism Hypoparathyroidism Diabetes mellitus Hepatitis B C Positive test human immunodeficiency virus Any cardiac symptom receive drug cardiac disease Presence hemoglobinopathies except thalassemia intermedia pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Hydroxyurea</keyword>
	<keyword>magnesium chloride</keyword>
	<keyword>L-carnitine</keyword>
	<keyword>β-thalassemia intermedia</keyword>
</DOC>